Arkadios Wealth Advisors
RDY icon

Arkadios Wealth Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

Arkadios Wealth Advisors’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,960
Closed -$38K – 1495
2021
Q3 		$38K Buy
2,960
+1,565
+112% +$20.9K 0.01% 979
2021
Q2 		$20K Buy
1,395
+960
+221% +$13.4K ﹤0.01% 1297
2021
Q1 		$5K Buy
+435
New +$5.59K ﹤0.01% 1376

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Arkadios Wealth Advisors's RDY Position: Q4 2021 in Review

Arkadios Wealth Advisors sold out of Dr. Reddy's Laboratories (RDY) in Q4 2021, closing a stake of 2,960 shares — an estimated $38K sold.

Arkadios Wealth Advisors first reported a position in RDY in Q1 2021 and held it in 3 quarters. The position peaked at $38K in Q3 2021. 147 funds tracked by Wall St. Rank hold RDY as of Q4 2021.

  • Arkadios Wealth Advisors reported no remaining Dr. Reddy's Laboratories position as of Q4 2021 after selling out during the quarter.
  • Arkadios Wealth Advisors sold 2,960 Dr. Reddy's Laboratories shares in Q4 2021, an estimated $38K.
  • Arkadios Wealth Advisors first reported a position in Dr. Reddy's Laboratories in Q1 2021 and held it in 3 quarters.
  • Arkadios Wealth Advisors's Dr. Reddy's Laboratories position peaked at $38K in Q3 2021.
  • 147 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2021.

Based on Arkadios Wealth Advisors's 13F filing for Q4 2021, filed 3 Feb 2022.